# A Study of Depemokimab in Participants of 6 to 11 Years of Age

> **NCT07671001** · PHASE3 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 34 (estimated)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** Depemokimab

## Key facts

- **NCT ID:** NCT07671001
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-25
- **Primary completion:** 2027-03-01
- **Final completion:** 2028-11-24
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671001, "A Study of Depemokimab in Participants of 6 to 11 Years of Age". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07671001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*